In the patent for "US Patent 6117912 - Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions" it is stated that
"The present invention is based upon the discovery that certain diseases and
conditions for which selegiline is known to be useful are surprisingly and
unexpectedly more advantageously treated by administering selegiline
buccally or sublingually rather than by administering selegiline using
prior art methods, e.g., oral administration. Accordingly, the novel
methods disclosed herein produce enhanced therapeutic effects."
Here is no hint regarding oral toxicity. On the website of the world intellectual property organization you find the following statement:
"Selegiline provides neuroprotection or neuronal rescue, by one or more mechanisms, for example, by reducing oxidative neuronal damage, increasing the amount of the enzyme superoxide dismutase, and/or reducing dopamine catabolism. PCT Published Application WO 92/17169 discloses that selegiline acts by directly maintaining, preventing loss of, and/or assisting in, the nerve function of animals. [...]" ((WO/1997/017067) SUBLINGUAL AND BUCCAL ADMINISTRATION OF SELEGILINE"
There is an article: "Sublingual selegiline (new formulation) Oral toxicity further compounds already unfavourable risk-benefit ratio". I haven't checked yet if I can use my world wide library access to read that article for free.
But you can try yourself - it can be found here:
http://direct.bl.uk/...om=searchengineNow switching to another interesting topic - how to prepare a selegiline to be more bioavailable:
Have a look on the "Sublingual Selegiline Tablet (Effervescent)" example below.
There you find that the additional key ingredients are: Citric Acid & Fumaric Acid. Those 2 substances seem to improve biovailability a great deal (Somewhere I have that study about Effervescent).
"DETAILED DESCRIPTION OF THE INVENTION
EXAMPLE 1
Buccal Selegiline Tablet
A buccal tablet is formulated from the following ingredients:
______________________________________
Ingredient Weight (mg/unit dose)
______________________________________
Selegiline HCl 5.00
Hydroxypropylmethlycellulose (HPMC) 5.00
Lactose 186.00
Citric Acid (anhydrous) 2.00
Magnesium stearate 2.00
______________________________________
Prepare a granulate from the first four ingredients by first passing
ingredients 1, 3 and 4 though a 25-mesh hand screen and thereafter blend.
Prepare a 10% solution of HPMC in water (10 g HPMC per 100 g of solution)
and granulate this solution into the dry ingredients. Pass the wet mass
through a #10 screen and spread onto a paper-lined tray, drying for three
hours at 130° C. Blend the resulting granulate with ingredient 5
and compress into a tablets.
EXAMPLE 2
Sublingual Selegiline Tablet (Non-Effervescent)
A sublingual tablet is prepared from the following ingredients:
______________________________________
Ingredient Weight (mg/unit dose)
______________________________________
Selegiline HCl 5.00
Croacarmellose sodium 5.00
Lactose 186.00
Citric Acid (anhydrous) 2.00
Magnesium stearate 2.00
______________________________________
Pass the first three ingredients above through a 25-mesh hand screen and
blend and mix for seven minutes. After passing ingredient 4 above through
a #60 hand mesh, add to the mix with the remaining blended ingredients and
blend for an additional 3 minutes. Compress the resulting mixture into
tablets.
EXAMPLE 3
Sublingual Selegiline Tablet (Effervescent)
A sublingual tablet is prepared from the following ingredients:
______________________________________
Ingredient Weight (mg/unit dose)
______________________________________
Selegiline HCl 5.00
Citric Acid (anhydrous) 100.00
Sodium bicarbonate 185.00
Fumaric acid 10.00"
______________________________________
Sources:
http://www.patentsto...escription.htmlhttp://www.wipo.int/...mp;DISPLAY=DESChttp://direct.bl.uk/...om=searchengineCheers Alex
--------------------
I have posed a valid point. Read the article on sublingual selegiline being orally toxic. I have also posed a valid point in warning people about the percentage of metabolites created by the liver via the oral route. If the buccal administration bypasses liver metabolism, that is great. However, oral toxicity is still a real threat, and the buccal route for many drugs only reduce metabolite creation by around 90%.
I pose a question to all of you; what do I have to gain by telling you all to be wary of administering selegiline? Only sellers have much to gain.
I think your presuming that I have given out pseudo-scientific knowledge borders on arrogance. The reality is that it is you who has espoused pseudo-intelligence by abusing the number of posts you have made and misdirecting people into blindly believing that something they are taking is safe. If you really believed in science, you would have at least taken some time to consider the issue of oral toxicity of sublingual forms of selegiline. Unfortunately, you have not. From this I have to conclude that you do not adopt a scientific attitude to viewing things.
You also seem to demoralize people for raising viewpoints supported by scientific papers. Perhaps you should refrain from rejecting scientific facts and take a hard look at the evidence that I've given. That is what I call a good scientific approach.
Edited by brotherx, 20 August 2008 - 10:05 AM.